FDA Developing Predictive Database To Help Screen Rx Imports
Executive Summary
FDA is working with the New Mexico State University Physical Sciences Lab to develop a predictive database to help allocate resources for intercepting prescription drug imports
You may also be interested in...
FDA Anticounterfeit Carrot & Stick: Radio Frequency I.D., No Paper Pedigree
FDA's anticounterfeiting strategy advocates radio frequency identification in lieu of paper pedigrees to secure the drug supply chain
Reimportation Should Await Track/Trace Technology, HIGPA White Paper Says
Providers interested in acquiring pharmaceuticals from outside the U.S. should first concentrate on advocacy for stronger anti-counterfeiting protections, the Health Industry Group Purchasing Association recommends in a product sourcing "white paper.
Roxane's Cafcit Approval Based On Post-Hoc Analysis Of Phase III Trial
FDA approved Roxane's Cafcit (caffeine citrate) on Sept. 21 based on a literature review and a post-hoc analysis of secondary endpoints from a Phase III trial.